Diabetes PubMed

  • Increase font size
  • Default font size
  • Decrease font size
Home Lifestyle Blood Glucose Control Glucose meter Comparison in the Performance of Glucose Meters in Blood Glucose Monitoring during Pregnancy

Comparison in the Performance of Glucose Meters in Blood Glucose Monitoring during Pregnancy

Gynecol Obstet Invest. 2010 Jan 21;69(4):264-269.

Kong GW, Tam WH, Chan MH, So WY, Lam CW, Yiu IP, Loo KM, Li CY.

Department of Obstetrics and Gynaecology, Prince of Wales Hospital, Hong Kong, SAR, China.

Aims: To compare the performance of the four latest models of glucose meters in capillary blood glucose monitoring during pregnancy. Methods: 208 pregnant women with gestational diabetes were recruited. Each subject had simultaneous capillary glucose monitoring by two study glucose meters and venous plasma glucose assay. The performance of four glucose meters was compared using error grid analysis (EGA) and the agreement between the meter readings and plasma glucose by Bland-Altman plot analysis. Results: Elite, Advantage II and CareSens had more than 90% of readings in the acceptable target range of EGA. CareSens had the lowest mean bias by Bland-Altman analysis while Advantage II had the highest proportion of readings within 5% difference from plasma glucose. Readings from all glucose meters except Optium were not influenced by the change in maternal hematocrit levels. Conclusions: The performance of four study glucose meters appeared very similar. Copyright © 2010 S. Karger AG, Basel.

PMID: 20090357

 

Bookmark and Share

Popular Diabetes PubMed Citations

Newsflash

Millions unite for diabetes awareness on World Diabetes Day 2010
Starting today, people from all corners of the world are uniting together for three days of celebration to put diabetes firmly in the public spotlight. World Diabetes Day is the best opportunity there is to draw attention to the silent killer that is diabetes.
 
Bristol-Myers Squibb Foundation Launches $100 Million Initiative
The Bristol-Myers Squibb Foundation announced Together on Diabetes®: Communities Uniting to Meet America's Diabetes Challenge, a 5-year, $100 million initiative to help patients living with type 2 diabetes better manage their disease beyond the doors of their doctor's office - in their homes and communities - and for the course of their disease.
 
New global survey reveals more than one in three patients fail to take insulin as prescribed
More than one in three diabetes patients skip doses or fail to take their insulin as prescribed, stating that they have done so on average three times in the last month, and 77% of physicians estimate that in reality this number could be as high as six doses*, according to the Global Attitudes of Patients and Physicians in Insulin Therapy (GAPPTM) survey, released today by Novo Nordisk.
 

Facebook Page Twitter Subscribe to Latest Diabetes PubMed facts... by Email RSS

Subscribe

Get Diabetes PubMed facts delivered by email. Enter your email address:


Delivered by FeedBurner

Who's Online

We have 2 guests online

Sponsored Links

PharmaNews.eu
PharmaNews.eu - the dynamic European pharmaceutical news engine.
www.pharmanews.eu

Advertise here